Serum adiponectin in elderly men does not correlate with fracture risk.

CONTEXT Recent evidence suggests that adiponectin may play a role in bone metabolism, but studies of the correlation between serum adiponectin and bone mineral density (BMD) have given conflicting results, and the impact on fracture risk is unknown. OBJECTIVE Our objective was to investigate the association between serum adiponectin levels and BMD and fracture risk. DESIGN, SETTING, PARTICIPANTS, MAIN OUTCOME MEASURES: We used regression analyses to estimate the relationship between adiponectin and BMD in the Prospective Investigation of the Vasculature in Uppsala Seniors cohort of 441 men and 457 women aged 70 yr. The association was thereafter analyzed in the Uppsala Longitudinal Study of Adult Men (ULSAM), in which adiponectin was analyzed at age 70 yr and BMD at 82 yr in 507 men. Fractures in the ULSAM were documented in 314 men during 15 yr follow-up. Cox regression analysis was used to determine the risk of fracture according to serum adiponectin levels. RESULTS In multivariable analysis a negative association between adiponectin and BMD was found in both cohorts. When individuals in the highest quintile of adiponectin were compared with those in the lowest quintile, adjusted BMD was 9.7% lower at the lumbar spine, 7.1% lower at the proximal femur, and 5.2% lower for total body in the Prospective Investigation of the Vasculature in Uppsala Seniors (P < 0.001 for all three), and 8.1, 5.1, and 4.1% (P < 0.003 for all three), respectively, in the ULSAM. However, the hazard ratio for fracture per 1 sd of serum adiponectin was 0.99 (95% confidence interval 0.89-1.11). CONCLUSION Although adiponectin was a negative determinant of BMD in two independent cohorts, it was not associated with fracture risk in men.

[1]  S. Hanazawa,et al.  Adiponectin inhibits induction of TNF‐α/RANKL‐stimulated NFATc1 via the AMPK signaling , 2008, FEBS letters.

[2]  中島 玲子.  Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans , 2008 .

[3]  H. Xie,et al.  Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[4]  L. Lind,et al.  Brachial Artery Intima-Media Thickness and Echogenicity in Relation to Lipids and Markers of Oxidative Stress in Elderly Subjects:-The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study , 2008, Lipids.

[5]  J. Cauley,et al.  Diabetes mellitus, bone mineral density, and fracture risk , 2007, Current opinion in endocrinology, diabetes, and obesity.

[6]  S. Yano,et al.  Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells , 2007, BMC Cell Biology.

[7]  J. Jürimäe,et al.  Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables. , 2007, American journal of physiology. Endocrinology and metabolism.

[8]  M. Vitai,et al.  Relations between bone status and glucose metabolism with progression of insulin resistance , 2007 .

[9]  M. Goldstein,et al.  Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. , 2007, The Journal of clinical endocrinology and metabolism.

[10]  K. Michaëlsson,et al.  Leisure Physical Activity and the Risk of Fracture in Men , 2007, PLoS medicine.

[11]  T. Spector,et al.  Serum adiponectin and bone mineral density in women. , 2007, The Journal of clinical endocrinology and metabolism.

[12]  J. Jürimäe,et al.  Adiponectin is a predictor of bone mineral density in middle-aged premenopausal women , 2007, Osteoporosis International.

[13]  C. Berne,et al.  Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. , 2007, The Journal of clinical endocrinology and metabolism.

[14]  S. Hanazawa,et al.  Adiponectin inhibits osteoclast formation stimulated by lipopolysaccharide from Actinobacillus actinomycetemcomitans. , 2007, FEMS immunology and medical microbiology.

[15]  大島 和也.  Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast , 2007 .

[16]  田村 朋子.  Serum leptin and adiponectin are positively associated with bone mineral density at the distal radius in patients with type 2 diabetes mellitus , 2007 .

[17]  M. Vitai,et al.  [Effect of progressive insulin resistance on the correlation of glucose metabolism and bone status]. , 2007, Orvosi hetilap.

[18]  Sun Woo Kim,et al.  Identification of adiponectin and its receptors in human osteoblast‐like cells and association of T45G polymorphism in exon 2 of adiponectin gene with lumbar spine bone mineral density in Korean women , 2006, Clinical endocrinology.

[19]  S. Saetung,et al.  Relationship of body composition and circulatory adiponectin to bone mineral density in young premenopausal women. , 2006, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[20]  H. Xie,et al.  Adiponectin Stimulates RANKL and Inhibits OPG Expression in Human Osteoblasts Through the MAPK Signaling Pathway , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  Kozo Nakamura,et al.  Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways , 2006, Journal of cellular biochemistry.

[22]  Kohjiro Ueki,et al.  Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. , 2006, The Journal of clinical investigation.

[23]  L. Lind.  Systolic and diastolic hypertension impair endothelial vasodilatory function in different types of vessels in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study , 2006, Journal of hypertension.

[24]  E. Ingelsson,et al.  Adiponectin and risk of congestive heart failure. , 2006, Journal of the American Medical Association (JAMA).

[25]  Lars Lind,et al.  A Comparison of Three Different Methods to Evaluate Endothelium-Dependent Vasodilation in the Elderly: The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[26]  H. Xie,et al.  Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. , 2005, Experimental cell research.

[27]  H. Parving,et al.  Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications , 2005, Diabetologia.

[28]  Won-Young Lee,et al.  The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle‐aged men , 2005, Clinical endocrinology.

[29]  J. Cauley,et al.  Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. , 2005, Archives of internal medicine.

[30]  K. Michaëlsson,et al.  Smoking and the Risk of Fracture in Older Men , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  J. Jürimäe,et al.  Adiponectin is Associated with Bone Mineral Density in Perimenopausal Women , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[32]  C. Drevon,et al.  Adiponectin and its receptors are expressed in bone-forming cells. , 2004, Bone.

[33]  T. Tai,et al.  Lack of independent relationship between plasma adiponectin, leptin levels and bone density in nondiabetic female adolescents , 2004, Clinical endocrinology.

[34]  L. Weinehall,et al.  Leptin, but not adiponectin, predicts stroke in males , 2004, Journal of internal medicine.

[35]  Nader Rifai,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[36]  B. Goldstein,et al.  Adiponectin: A novel adipokine linking adipocytes and vascular function. , 2004, The Journal of clinical endocrinology and metabolism.

[37]  U. Dafni,et al.  Blood Leptin and Adiponectin as Possible Mediators of the Relation Between Fat Mass and BMD in Perimenopausal Women , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[38]  S. Ishibashi,et al.  Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. , 2003, Metabolism: clinical and experimental.

[39]  K. Lohman,et al.  Adiponectin as a novel determinant of bone mineral density and visceral fat. , 2003, Bone.

[40]  K. Michaëlsson,et al.  Serum retinol levels and the risk of fracture. , 2003, The New England journal of medicine.

[41]  Jonathan Krakoff,et al.  Adiponectin and development of type 2 diabetes in the Pima Indian population , 2002, The Lancet.

[42]  Y. Terauchi,et al.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.

[43]  P. Scherer,et al.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.

[44]  NoriyukiOuchi,et al.  Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages , 2001 .

[45]  大内 乗有.  Novel modulator for endothelial adhesion molecules : Adipocyte-derived plasma protein adiponectin , 2001 .

[46]  S. Cummings,et al.  Older women with diabetes have an increased risk of fracture: a prospective study. , 2001, The Journal of clinical endocrinology and metabolism.

[47]  H. Heinzl,et al.  Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions. , 1997, Computer methods and programs in biomedicine.

[48]  S. Cummings,et al.  Bone density at various sites for prediction of hip fractures , 1993, The Lancet.